Clinical Trials Browser

Nausea × Gastrointestinal × 1 year × Clear all

Digestive System Neoplasms, Lung Neoplasms, Nausea, Neoplasms, Vomiting

NCT03499808 2025-09-09

S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis

Lymphadenopathy, Immunoglobulin Light-chain Amyloidosis, Constipation, Diarrhea, Gastrointestinal Hemorrhage, Hepatomegaly, Macroglossia, Nausea, Purpura

Clinical Trials

REFYO-R

S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis